Tianeptine, first created as a mood-boosting compound in the 1980s, has ignited considerable controversy internationally. Unlike typical antidepressants which act by increasing serotonin levels, tianeptine seems to enhance serotonin reuptake and affects brain chemistry, resulting in atypical responses. Its accessibility on the copyright, often avoi